Enlivex Therapeutics Ltd (ENLV) — Tangible Net Worth Ratio
Enlivex Therapeutics Ltd (ENLV) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets (ILA0.00) from net assets (ILA17.48 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Enlivex Therapeutics Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Enlivex Therapeutics Ltd Tangible Net Worth Ratio (2012–2024)
This chart shows how Enlivex Therapeutics Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of ILA17.48 Million with intangible assets of ILA0.00 ILA. See Enlivex Therapeutics Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Enlivex Therapeutics Ltd (2012–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Enlivex Therapeutics Ltd from 2012 to 2024, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see ENLV market cap overview.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | ILA23.59 Million | ILA0.00 | ILA27.69 Million | ▲ +0.0 pp |
| 2023 | 100.0% | ILA30.08 Million | ILA0.00 | ILA36.83 Million | ▲ +0.0 pp |
| 2022 | 100.0% | ILA56.84 Million | ILA0.00 | ILA67.64 Million | ▲ +0.0 pp |
| 2021 | 100.0% | ILA85.04 Million | ILA0.00 | ILA95.15 Million | ▲ +0.0 pp |
| 2020 | 100.0% | ILA35.49 Million | ILA0.00 | ILA40.36 Million | ▲ +3.6 pp |
| 2019 | 96.4% | ILA11.28 Million | ILA410.00K | ILA17.56 Million | ▼ -3.6 pp |
| 2018 | 100.0% | ILA9.71 Million | ILA0.00 | ILA11.03 Million | ▲ +0.0 pp |
| 2017 | 100.0% | ILA3.16 Million | ILA0.00 | ILA3.62 Million | ▲ +0.0 pp |
| 2016 | 100.0% | ILA8.70 Million | ILA0.00 | ILA10.63 Million | ▲ +0.0 pp |
| 2015 | 100.0% | ILA17.93 Million | ILA0.00 | ILA20.52 Million | ▲ +0.0 pp |
| 2014 | 100.0% | ILA30.67 Million | ILA0.00 | ILA32.95 Million | ▲ +0.0 pp |
| 2013 | 100.0% | ILA5.55 Million | ILA0.00 | ILA5.69 Million | ▲ +0.0 pp |
| 2012 | 100.0% | ILA75.00K | ILA0.00 | ILA156.00K | — |